Qu Biologics Inc.

About Qu Biologics Inc.

Qu Biologics is a biotechnology company focused on transforming the treatment and prevention of cancer, chronic inflammatory diseases, and metabolic disease by restoring normal immune function through their proprietary Site Specific Immunomodulators (SSIs).

Products & Services

Site Specific Immunomodulators (SSIs):A first-in-class immunotherapy platform designed to restore normal immune function and treat conditions like cancer, chronic inflammatory diseases, metabolic disease, and aging by harnessing the body's natural immune response.

QBECO SSI:A specific SSI being evaluated in the PERIOP-06 Study to prevent post-operative innate immune suppression and improve survival in late-stage colon cancer patients undergoing surgery for liver metastasis.

Specialties

Immunotherapy Site Specific Immunomodulators (SSIs) Cancer Treatment Chronic Inflammatory Diseases Metabolic Disease Aging-Related Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 450000 MR: - FA: $450,000 FAN: 450000	D: 2024-03-11 FD: 2024-03-11	3 investors
2	RT: Grant T: - FT: Grant	A: 400000 MR: - FA: CAD$400,000 FAN: 400000	D: 2023-11-14 FD: 2023-11-14	2 investors

Grant Latest

2024-03-11

$450K

3 investors (Pro only)

Grant 2023-11-14

$400K

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Hal Gunn, MD

CEO

S

Simon Sutcliffe, MD, FRCP, FRCPC, FRCR

Chief Medical Officer - Oncology

T

Ted Steiner, MD, FRCPC

Chief Medical Officer - Infectious Diseases

S

Shirin Kalyan, PhD

Vice President - Scientific Innovation

A

Arjune Premsukh, BSc

Vice President - Chemistry, Manufacturing, and Control

R

Robert E. Pelzer, LLB

Accomplished Pharmaceutical Leader

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Qu Biologics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised